oxaliplatin 5 mg/ml concentrate for solution for infusion
fresenius kabi deutschland gmbh - oxaliplatin - concentrate for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin
platinox-v
vitamed pharmaceutical industries ltd - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg / 1 ml - oxaliplatin - oxaliplatin in combination with 5- fluorouracil (5-fu) and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumour. - treatment of metastatic colorectal cancer.oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).
oxaccord oxaliplatin concentrate for solution for infusion usp 5 mgml
accord healthcare private limited - oxaliplatin - infusion, solution concentrate - oxaliplatin 5 mg
oxaliplatin advagen concentrate for solution for infusion 5mgml
advagen pte. ltd. - oxaliplatin - infusion, solution concentrate - oxaliplatin 5mg/ml
oxaliplatin sandoz concentrate for solution for infusion 5mgml
sandoz singapore pte. ltd. - oxaliplatin - infusion, solution concentrate - 5mg/ml - oxaliplatin 5mg/ml
eloxatin for intravenous infusion 100 mg/vial
sanofi-aventis singapore pte. ltd. - oxaliplatin - injection, powder, for solution - 100 mg/vial
eloxatin for intravenous infusion 50 mg/vial
sanofi-aventis singapore pte. ltd. - oxaliplatin - injection, powder, for solution - 50 mg/vial
eloxatin concentrate for soln for inf 5mg/ml (10ml vial)
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
oxaliplatin 5mg/ml concentrate for solution for infusion
accord healthcare limited - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents
oxaliplatin ebewe 5mg/ml powder for infusion
ebewe pharma gmbh nfg. kg - oxaliplatin 5 mg/ml - powder for solution for infusion